Skip to main content
Skip to main content
HCA logo

HCA Healthcare, Inc. (HCA) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$421.21 -$0.62 (-0.15%) |Exceptional · 81
HCA Healthcare, Inc. (HCA) bottom line: Bullish Lean — our Council read (69/100) and AI Score (81/100) broadly agree. Strongest signal: Growth Durability · Biggest watch-out: Momentum.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $91.2B| P/E Ratio: 14.06| Vol: 1.4M| Target: $455.19 (+8.1%) (Aug 25, 2026) (estimate, not advice)|

P/E 14.06 means the share price is 14.06 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $91.2B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

HCA Healthcare, Inc. (HCA) trades at $421.21 with MoonshotScore 81/100 (Grade A+). HCA Healthcare, Inc. is a leading provider of healthcare services in the United States, operating a vast network of hospitals and outpatient facilities. Market cap: $91.2B, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: May 10, 2026
HCA Healthcare, Inc. is a leading provider of healthcare services in the United States, operating a vast network of hospitals and outpatient facilities. With a strong focus on patient care and operational efficiency, HCA is positioned to capitalize on the growing demand for healthcare services.

HCA stock analysis for 2026: Analysts have set a consensus price target of $455.19 for HCA Healthcare, Inc., suggesting 8.1% upside from the current price of $421.21. The AI MoonshotScore is 81/100, in the Exceptional band (80-100) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the HCA film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 69/100 · B+

HCA: 2/3 scored disciplines lean bullish. Dominant signal: Growth Durability strong.

How is this calculated? →
MoonshotScore · Five-pillar engine · 81/100
Business Quality
Moderate Is this a genuinely good business?
Financial Safety
Neutral Could this blow up on me?
Valuation
Strong Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Neutral Is the market already moving on this?

Strongest side: Growth Durability (9/10, Strong). Weakest side: Momentum (5/10, Neutral).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Favorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Neutral read
Moon AI lens (model)
Favorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

HCA Healthcare, Inc. (HCA) Healthcare & Pipeline Overview

CEOSamuel N. Hazen
Employees230,000
HeadquartersNashville, TN, US
IPO Year2011

HCA Healthcare, Inc. stands as a premier healthcare services provider in the U.S., operating a comprehensive network of hospitals and outpatient facilities, delivering a wide array of medical and surgical services while maintaining a focus on quality patient care and operational excellence.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: May 10, 2026

What Is the Investment Thesis for HCA?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

With a market capitalization of $91.2B and a P/E ratio of 14.06, HCA demonstrates strong profitability, evidenced by a profit margin of 8.9% and a gross margin of 34.9%. The company is well-positioned to benefit from the ongoing expansion of healthcare services, particularly as the demand for outpatient care continues to rise. HCA's strategic focus on operational excellence, combined with its extensive network of facilities, allows it to capture market share in an increasingly competitive landscape. Additionally, the company's dividend yield of 0.68% provides a steady income stream for investors. However, potential risks, including regulatory changes and market competition, must be monitored closely as they could impact future growth.

Based on FMP financials and quantitative analysis

HCA Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $91.2B indicates strong market presence in the healthcare sector.

  • P/E ratio of 14.06 reflects a competitive valuation relative to peers.
  • Profit margin of 8.9% demonstrates effective cost management and operational efficiency.
  • Gross margin of 34.9% exceeds industry averages, indicating strong profitability.
  • Dividend yield of 0.68% provides a steady return to shareholders.

Who Are HCA's Competitors?

HCA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
PFE Pfizer Inc. $27.65 -0.47% $158B 665-pillar
BMY Bristol-Myers Squibb Company $63.75 -1.02% $130B 905-pillar
SNY Sanofi $42.74 -0.25% $103B 835-pillar
VRTX Vertex Pharmaceuticals Incorporated $519.58 -0.29% $132B 965-pillar
CVS CVS Health Corporation $95.29 -0.09% $122B 695-pillar
FSNUY Fresenius SE & Co. KGaA $13.00 +0.62% $117B 439-signal
THC Tenet Healthcare Corporation $263.46 -2.09% $21.2B 885-pillar
SOLV Solventum Corporation $87.80 -2.48% $15.2B 595-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are HCA's Key Strengths?

Large scale of operations with 182 hospitals and numerous outpatient facilities.

  • Strong financial performance with consistent revenue growth.
  • Diverse service offerings catering to a wide range of patient needs.
  • Established reputation for quality care and patient satisfaction.

What Are HCA's Weaknesses?

High operational costs associated with running extensive healthcare facilities.

  • Regulatory challenges in the healthcare industry may impact operations.
  • Dependence on government reimbursement programs for a significant portion of revenue.
  • Potential vulnerabilities to economic downturns affecting patient volumes.

What Could Drive HCA Stock Higher?

Expansion of outpatient services to meet rising patient demand.

  • Strategic acquisitions to enhance geographic reach and service offerings.
  • Investment in technology to improve operational efficiency and patient care.
  • Initiatives to expand mental health services in response to societal needs.

What Are the Key Risks for HCA?

Insider selling — insiders were net sellers of roughly $3.3M recently.

  • Regulatory changes impacting reimbursement rates and operational practices.
  • Competition from other healthcare providers and emerging startups.
  • Economic fluctuations affecting patient volumes and insurance coverage.
  • Rising costs of healthcare delivery impacting profit margins.

What Are the Growth Opportunities for HCA?

  • By enhancing its outpatient facilities and services, HCA can attract more patients seeking convenient, cost-effective care options.
  • Technological Advancements in Healthcare: The integration of advanced technologies in healthcare delivery is expected to drive significant growth. HCA's investment in telehealth services and electronic health records positions the company to improve patient outcomes and operational efficiency, tapping into a market projected to grow at a CAGR of 15% through 2026.
  • Strategic Acquisitions: HCA has a history of strategic acquisitions that enhance its service offerings and geographic reach. With a focus on acquiring complementary healthcare facilities, HCA can expand its footprint in underserved markets, potentially increasing its patient base and revenue streams.
  • Aging Population: The increasing number of elderly individuals in the U.S. is expected to drive demand for healthcare services. HCA's comprehensive service offerings, particularly in geriatric care, position it to meet this rising demand, contributing to sustained revenue growth over the next decade.
  • Mental Health Services Expansion: HCA's operation of psychiatric hospitals allows it to address the growing need for mental health services, which is projected to grow to a $240 billion market by 2030. By enhancing its mental health programs, HCA can capture a larger share of this expanding market.

What Are HCA's Competitive Advantages?

  • Extensive network of hospitals and outpatient facilities enhances accessibility.
  • Strong brand recognition and reputation for quality care in the healthcare sector.
  • Diverse service offerings reduce dependency on any single revenue stream.
  • Operational efficiencies gained from scale provide a competitive advantage.
  • Commitment to innovation and technology adoption improves patient care.

What Does HCA Do?

HCA Healthcare, Inc., founded in 1968, is a prominent health care services company headquartered in Nashville, Tennessee. Originally known as HCA Holdings, Inc., the company has evolved significantly over the decades, expanding its operations to become one of the largest healthcare providers in the United States. HCA operates a diverse range of healthcare facilities, including general and acute care hospitals, outpatient surgery centers, and urgent care facilities, among others. As of December 31, 2021, HCA managed 182 hospitals, comprising 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals across 20 states and England. The company also boasts a robust network of outpatient healthcare facilities, including 125 freestanding surgery centers and 21 freestanding endoscopy centers. HCA's extensive service offerings encompass inpatient care, intensive care, cardiac care, diagnostic and emergency services, as well as outpatient services like laboratory, radiology, and physical therapy. HCA's commitment to providing high-quality healthcare is evident in its operational strategies and the therapeutic programs offered in its psychiatric hospitals, which cater to various demographics. With a workforce of approximately 320,000 employees, HCA is dedicated to advancing healthcare delivery and improving patient outcomes through its comprehensive and innovative services.

What Products and Services Does HCA Offer?

  • Operate general and acute care hospitals providing comprehensive medical services.
  • Offer outpatient services including surgery, laboratory, and rehabilitation.
  • Manage freestanding ambulatory surgery and emergency care centers.
  • Provide psychiatric care and substance abuse treatment programs.
  • Deliver diagnostic imaging and therapy services through specialized centers.
  • Engage in community health initiatives to improve overall public health.

How Does HCA Make Money?

  • Generate revenue through patient services in hospitals and outpatient facilities.
  • Offer specialized medical services that cater to diverse patient needs.
  • Leverage economies of scale across a large network of healthcare facilities.
  • Implement cost management strategies to enhance profitability.
  • Engage in partnerships and collaborations to expand service offerings.

What Industry Does HCA Operate In?

The healthcare industry, particularly the medical care facilities sector, is experiencing significant growth driven by an aging population and increasing demand for healthcare services. The market is projected to expand as technological advancements and shifts towards outpatient care reshape service delivery. HCA Healthcare, Inc. is strategically positioned within this landscape, leveraging its extensive network of hospitals and outpatient facilities to meet the evolving needs of patients. The competitive landscape includes major players like Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY), Sanofi (SNY), Vertex Pharmaceuticals Incorporated (VRTX), and CVS Health Corporation (CVS), all vying for market share in a rapidly changing environment.

Who Are HCA's Key Customers?

  • Patients seeking inpatient and outpatient medical care.
  • Insurance companies providing coverage for healthcare services.
  • Government programs such as Medicare and Medicaid.
  • Employers offering health benefits to employees.
  • Community organizations and health agencies collaborating on public health initiatives.
Model self-rating on this text: 73% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

High 100/100

Broad, current evidence sits behind this analysis.

  • Scored on 94% of our measures
  • Price is current
  • Latest filing 45 days ago
  • Covered by analysts

Why 81?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.54 Financial-health checklist (Financial Strength)
  • +0.52 Gross profit per dollar of assets (Business Quality)
  • +0.28 Return on invested capital (Business Quality)

What is holding it back

  • -0.41 Net debt vs earnings (Financial Strength)
  • -0.17 Return on equity (Business Quality)
  • -0.16 Short-term liquidity (Financial Strength)

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 84
2026-08-26 85
2026-08-29 86
2026-09-01 80
2026-09-04 80
2026-09-07 80
2026-09-10 80

What changed?

The grade moved from 84 to 80 (-4).

What moved it up or down:

  • -19 Financial Strength

Held back by:

  • +8 Momentum
  • +3 Valuation

Over the same 18 days the stock moved -1.7%.

Company Profile

HCA Healthcare, Inc. operates in the Medical Care Facilities industry within the Healthcare sector. It is headquartered in Nashville, United States.

HCA Healthcare, Inc. Financial Trajectory

HCA Healthcare, Inc. (HCA) reported $20.23B in revenue for Q2 FY2026, reflecting 5.9% growth compared to the prior quarter. The company recorded net income of $1.70B, with diluted EPS of $7.62. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Healthcare. Across the four most recent quarters, HCA averaged $7.42 in diluted EPS.

How HCA Healthcare, Inc. Is Valued

HCA Healthcare, Inc. carries a market capitalization of $91.2B, placing it in the large-cap category. Analyst price targets span from $369.00 to $579.00, with a consensus of $455.19. At the current price of $421.21, that implies approximately 8% upside potential. Relative to its peer group, HCA's quantitative score of 81/100 is roughly in line with the peer average of 74/100.

P/E 14.1

Key Financial Metrics

Return on assets is 11.3%, showing how much profit it generates from its asset base. HCA trades at a trailing price-to-earnings ratio of 14.06, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 6.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.78 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 7.5%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9

Financial Health

HCA Healthcare, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.59 places it in the grey zone, a middle ground that warrants monitoring.

5/8 beats

Earnings Track Record

HCA Healthcare, Inc. has beaten Wall Street's EPS estimate in 5 of its last 8 reported quarters — more hits than misses. Reported results have landed about 6.4% above estimates on average.

Net selling

Insider Activity

Over the past six months, HCA Healthcare, Inc. insiders filed 11 SEC Form 4 transactions — 2 sales and 9 purchases. On net that is roughly 2K shares disposed (about $3.3M), a signal worth weighing alongside the fundamentals.

HCA Financials

Next earnings report:

HCA earnings history & estimates →

Fundamental Snapshot

Revenue Growth (FY)
+7.1%
Net Income Growth (FY)
+17.8%
EPS Growth (FY)
+28.5%
Free Cash Flow Growth (FY)
+36.4%
P/E (TTM)
14.06
Return on Equity (TTM)
-112.9%
Current Ratio
0.8
EV/EBITDA (TTM)
8.7

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Large scale of operations with 182 hospitals and numerous outpatient facilities.
  • Strong financial performance with consistent revenue growth.
  • Diverse service offerings catering to a wide range of patient needs.
  • Established reputation for quality care and patient satisfaction.

Bear Case

  • High operational costs associated with running extensive healthcare facilities.
  • Regulatory challenges in the healthcare industry may impact operations.
  • Dependence on government reimbursement programs for a significant portion of revenue.
  • Potential vulnerabilities to economic downturns affecting patient volumes.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $20.23B $1.70B $7.62
Q1 FY2026 $19.11B $1.62B $7.15
Q4 FY2025 $19.51B $1.88B $8.14
Q3 FY2025 $19.16B $1.64B $6.78

Q2 FY2026 · filed 28 Jul 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

HCA Latest News

HCA Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HCA.

Price Targets

Low
$369.00
Consensus
$455.19
High
$579.00

Median: $442.50 (+8.1% from current price)

Source: FMP analyst consensus · as of Aug 25, 2026 · an estimate, not advice

HCA MoonshotScore

81/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. HCA scores 81/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Latest HCA Healthcare, Inc. Analysis

Leadership: Samuel N. Hazen

CEO

Samuel N. Hazen has been with HCA Healthcare for over 30 years, holding various leadership roles that have shaped the company's strategic direction. He holds a Bachelor of Science in Business Administration from the University of Florida and has extensive experience in healthcare management and operations.

Track Record: Under Hazen's leadership, HCA has achieved significant operational efficiencies and expanded its service offerings, enhancing patient care and satisfaction. He has been instrumental in driving HCA's growth strategy, including strategic acquisitions and technological advancements.

Common Questions About HCA (Healthcare)

What does the AI Score mean for HCA?

HCA holds an AI Score of 81/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is HCA a good stock?

Stock Expert AI does not rate HCA buy, sell or hold. HCA Healthcare, Inc. carries a MoonshotScore of 81/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about HCA stock?

Analysts generally view HCA Healthcare, Inc. positively, citing its strong market position and financial performance. Key valuation metrics indicate a P/E ratio of 14.06, which is competitive within the industry.

What are the key factors to evaluate for HCA?

HCA Healthcare, Inc. (HCA) holds an AI score of 81/100 (high). P/E: 14.06x vs the S&P 500's ~20-25x. Analysts target $455.19 (+8%). Not financial advice.

How frequently does HCA data refresh on this page?

HCA's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven HCA's recent stock price performance?

HCA Healthcare, Inc. (HCA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Large scale of operations with 182 hospitals and numerous outpatient facilities. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider HCA overvalued or undervalued right now?

HCA Healthcare, Inc. (HCA) trades at 14.06x earnings. Analysts target $455.19 (+8%) — near fair value. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of HCA?

Yes, most major brokerages offer fractional shares of HCA Healthcare, Inc. (HCA) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track HCA's earnings and financial reports?

HCA Healthcare, Inc. (HCA) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for HCA earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • All information is based on the latest available data and may be subject to change.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover